Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127757483 | 12775748 | 3 | F | 20160317 | 20160425 | 20160923 | 20160923 | PER | US-PFIZER INC-3270142 | PFIZER | 50.00 | YR | F | Y | 105.00000 | KG | 20160923 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127757483 | 12775748 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous drip | DOSING PER AUC 5, ONCE EVERY 4WEEKS FOR 6 CYCLES | UNK | 76517 | |||||||||
| 127757483 | 12775748 | 2 | SS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | 30 MG/M2, FOR 6 CYCLES, FREQ: 1 WEEK; INTERVAL: 4 | UNK | 0 | 30 | MG/M**2 | |||||||
| 127757483 | 12775748 | 3 | SS | FARLETUZUMAB | FARLETUZUMAB | 1 | Intravenous drip | 5 MG/KG/ PLACEBO WEEKLY | UNK | 0 | |||||||||
| 127757483 | 12775748 | 4 | SS | FARLETUZUMAB | FARLETUZUMAB | 1 | Intravenous drip | 10 MG/KG/ PLACEBO AS A LOADING DOSE ONCE WEEKLY FOR 2 WEEKS OF TREATMENT | UNK | 0 | |||||||||
| 127757483 | 12775748 | 5 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | UNK | U | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127757483 | 12775748 | 1 | Ovarian cancer recurrent |
| 127757483 | 12775748 | 2 | Ovarian cancer recurrent |
| 127757483 | 12775748 | 3 | Ovarian cancer recurrent |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127757483 | 12775748 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127757483 | 12775748 | Blood glucose increased | |
| 127757483 | 12775748 | Blood urea nitrogen/creatinine ratio increased | |
| 127757483 | 12775748 | Dehydration | |
| 127757483 | 12775748 | Lipase increased | |
| 127757483 | 12775748 | Nausea | |
| 127757483 | 12775748 | Vomiting | |
| 127757483 | 12775748 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127757483 | 12775748 | 1 | 20160112 | 0 | ||
| 127757483 | 12775748 | 2 | 20160112 | 0 | ||
| 127757483 | 12775748 | 3 | 20160112 | 2016 | 0 | |
| 127757483 | 12775748 | 4 | 20160112 | 0 |